CONGENITAL GALACTOSEMIA IN NEONATAL PRACTICE: A CLINICAL CASE REPORT

Read full text Summarise with VIRAT
Authors: Ірина РЕДЬКО, A. Lobanov, Y. Tokarieva
Cited by: 0
References: 8

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Classical congenital galactosaemia continues to be associated with high mortality and long-term disability in affected infants, even with expanded neonatal screening in Ukraine. The purpose of the work is to highlight the diagnostic and management challenges associated with this rare inborn error of metabolism in neonates, particularly in settings with limited clinical experience among neonatologists, based on a single-centre observation. Material and methods of the study. The report describes the clinical course, diagnostic evaluation, and management of a newborn diagnosed with classical (type I) congenital galactosaemia. Diagnostic investigations comprised clinical examination, serial biochemical analyses (including serum bilirubin fractions and liver enzymes), chest radiography, abdominal ultrasonography with Doppler assessment, ophthalmoscopic fundus examination, and postmortem histopathological analysis. Results of the study. A full-term male infant with classical congenital galactosaemia presented with a severe clinical course culminating in death. The infant was delivered by caesarean section to a 38-year-old mother with a significant somatic and obstetric history. At birth, the newborn was in satisfactory condition and remained with the mother for the first 6 days of life while receiving exclusive breastfeeding. Jaundice developed on day 4 of life as the sole initial clinical manifestation. Expanded neonatal screening for 21 inherited metabolic disorders was performed on day 3. Progressive indirect hyperbilirubinaemia ensued despite intensive phototherapy. From day 7, clinical deterioration became evident, characterised by systemic intoxication, persistent hyperbilirubinaemia, hepatomegaly, and neurological abnormalities (hypotonia and hyporeflexia). The infant was transferred to a second-level neonatal care unit. On day 9, haemorrhagic syndrome developed in association with worsening biochemical parameters (rising conjugated bilirubin and hepatic transaminases), necessitating transfer to the neonatal intensive care unit with a provisional diagnosis of early-onset haemorrhagic disease, perinatal infection, and haemolytic jaundice. Ophthalmoscopic examination on day 13 revealed vitreous haemorrhages in the left eye. On day 14, the initial neonatal screening result was reported as positive for galactosaemia type I and was confirmed by repeat testing. Despite maximal supportive care, progressive multiorgan failure ensued, including severe intoxication, respiratory insufficiency, worsening neurological status, and disseminated intravascular coagulation, leading to death on day 14 of life. The diagnosis was confirmed postmortem by histopathological examination and the repeated positive screening result. Conclusions. Classical congenital galactosaemia typically presents with nonspecific early symptoms, and the current turnaround time for expanded neonatal screening results in Ukraine is approximately 10 days. Neonatologists should maintain a high index of suspicion in the presence of progressive jaundice with significant hyperbilirubinaemia, hepatomegaly with elevated transaminases, coagulopathy, and vitreous haemorrhages. Immediate initiation of a galactose-free and lactose-free formula is warranted pending confirmatory screening results.

Fields of Study & Subjects

Metabolism and Genetic Disorders Neonatal Health and Biochemistry Lysosomal Storage Disorders Research

Publication details

Journal / source
Neonatology surgery and perinatal medicine
Volume
16
Issue
1(59)
Pages
255–259
Publication date
27 March 2026
Language
EN